The use of two different APC resistance assay systems provides optimal sensitivity and specificity for diagnosmg genetic APC resistance

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 5, 1997, Pages 268-273

  Solano, C ^a   Hogg, A L ^a   Saal, R J ^a   Scott, D C ^a   Cobcroft, R G ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

APC resistance; dilute Russell's viper venom; Factor V Leiden; functional assay; sensitivity; specificity

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; LUPUS ANTICOAGULANT; VIPER VENOM;

ARTICLE; BIOASSAY; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE MUTATION; GENETIC DISORDER; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; RELIABILITY;

EID: 0030798117     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199707000-00002     Document Type: Article

References (24)

1. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci 1993; 90: 1004-1008.
2. Bertina RM, Koelman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
3. Trossaert M, Conrad J, Horellou MH, Samama MM. Influence of storage conditions on activated protein C resistance assay. Thromb Haemostas 1995; 73: 163-164.
4. Sidelmann J, Gram J, Pederson OD, Jespersen J. Influence of plasma platelets on activated protein C resistance assay. Thromb Haemostas 1995; 74: 993-994.
5. De Stefano V, Paciaroni K, Mastrangelo S, Rutella S, Bizzi B, Leone G. Instrument effect on the activated protein C resistance plasma assay performed by a commercial kit. Thromb Haemostas 1996; 75: 752-756.
6. Leroy-Matheron C, Levent M, Pignon JM, Mendonica C, Gouault-Heilmann M. The 1691 G-A mutation in the factor V gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients. Thromb Haemostas 1996; 75: 4-10.
7. Varadi K, Moritz B, Lang H, et al. A chromogenic assay for activated protein C resistance. Br J Haem 1995; 90: 884-891.
8. Halmayer WM, Haushofer A, Schon R, Fischer M. Influence of lupus anticoagulant on a commercially available kit for APC-Resistance. Thromb Haemostas 1994; 72: 645-646.
9. Legnani C, Palareti G, Biagi R, et al. Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation. Br J Haem 1996; 93: 694-699.
10. Jorquera JI, Montoro JM, Angeles Fernandez M, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994; 344: 1162-1163.
11. Tosetto A, Rodeghiro F. Diagnosis of APC Resistance in patients on oral anticoagulants. Thromb Haemostas 1995; 73: 732-733.
12. Martorell JR, Munoz-Castillo A, Gil JL. False positive activated protein C resistance test due to anti-phospholipid antibodies is corrected by platelet extract. Thromb Haemostas 1995; 74: 796-797.
13. Villa P, Aznar J, Jorquera JI, Casana P. Laboratory diagnosis of APC-Resistance in patients with lupus anticoagulant. Thromb Haemostas 1994; 74: 1606-1607.
14. Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralisation procedure. Am J Clin Pathol 1983; 79: 678-682.
15. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haem 1978; 40: 143-151.
16. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemostas 1995; 74: 449-453.
17. Henkens CMA, Bom VJJ, van der Meer J. Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity. Thromb Haemostas 1995; 74: 1198-1199.
18. Vasse M, Leduc O, Borg JY, Chretien MH, Monconduit M. Resistance to activated protein C: evaluation of three functional assays. Thromb Res 1994; 76: 47-59.
19. Laffan MA, Manning R. The influence of factor VIII on measurement of activated protein C resistance. Blood Coag Fibrinol 1996; 7: 761-765.
20. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haem 1995; 90: 725-727.
21. Oliviera O, Friso S, Manzato F, et al. Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haem 1995; 91: 465-470.
22. Ruiz-Arguelles GJ, Garces-Eisle J, Alarcon-Segovia D, Ruiz-Arguelles A. Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndrome. Blood Coag Fibrinol 1996; 7: 344-348.
23. Ehrenforth S, Radtke KP, Scharrer I. Acquired activated protein C resistance in patients with lupus anticoagulants. Thromb Haemostas 1995; 74: 793-810.
24. Bokarewa MI, Blomback M, Bremme K. Phospholipid antibodies and resistance to activated protein C in women with thrombophilia. Blood Coag Fibrinol 1995; 6: 417-422.